
Alicia L. Otton
Examiner (ID: 9618)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1699, 4121 |
| Total Applications | 1585 |
| Issued Applications | 975 |
| Pending Applications | 99 |
| Abandoned Applications | 544 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19049203
[patent_doc_number] => 20240091172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/767616
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767616 | DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF | Jun 2, 2020 | Pending |
Array
(
[id] => 16482407
[patent_doc_number] => 20200376007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/885905
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885905 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | May 27, 2020 | Abandoned |
Array
(
[id] => 16460680
[patent_doc_number] => 10844012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Antibacterial compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/885145
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13669
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885145 | Antibacterial compounds and methods of use thereof | May 26, 2020 | Issued |
Array
(
[id] => 16540911
[patent_doc_number] => 20200407324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT
[patent_app_type] => utility
[patent_app_number] => 16/883199
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883199 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | May 25, 2020 | Pending |
Array
(
[id] => 16540911
[patent_doc_number] => 20200407324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT
[patent_app_type] => utility
[patent_app_number] => 16/883199
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883199 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | May 25, 2020 | Pending |
Array
(
[id] => 16283708
[patent_doc_number] => 20200277310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/878425
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878425 | Podophyllotoxin derivatives and their use | May 18, 2020 | Issued |
Array
(
[id] => 16631871
[patent_doc_number] => 20210050525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/878338
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878338 | Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device | May 18, 2020 | Issued |
Array
(
[id] => 18153049
[patent_doc_number] => 11566009
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-31
[patent_title] => Energetic compound embodiments and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/875544
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 7463
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875544 | Energetic compound embodiments and methods of making and using the same | May 14, 2020 | Issued |
Array
(
[id] => 16268787
[patent_doc_number] => 20200270274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/870208
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870208 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | May 7, 2020 | Abandoned |
Array
(
[id] => 18588589
[patent_doc_number] => 11737457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Antimicrobial and foamable alcoholic compositions
[patent_app_type] => utility
[patent_app_number] => 16/864315
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6186
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864315 | Antimicrobial and foamable alcoholic compositions | Apr 30, 2020 | Issued |
Array
(
[id] => 17734661
[patent_doc_number] => 20220220120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CRYSTAL FORM OF WEE1 INHIBITOR COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/607447
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607447 | Crystal form of Wee1 inhibitor compound and use thereof | Apr 29, 2020 | Issued |
Array
(
[id] => 17784580
[patent_doc_number] => 11407692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Method for oxidative cleavage of compounds with unsaturated double bond
[patent_app_type] => utility
[patent_app_number] => 16/860690
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5066
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860690 | Method for oxidative cleavage of compounds with unsaturated double bond | Apr 27, 2020 | Issued |
Array
(
[id] => 16221198
[patent_doc_number] => 20200246314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => DYSLIPIDEMIA THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 16/853121
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853121 | DYSLIPIDEMIA THERAPEUTIC AGENT | Apr 19, 2020 | Abandoned |
Array
(
[id] => 16375030
[patent_doc_number] => 20200323872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/842539
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842539 | Heterocyclic compounds as RSV inhibitors | Apr 6, 2020 | Issued |
Array
(
[id] => 17837639
[patent_doc_number] => 20220274944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITE ABSORBENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/637241
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637241 | COMPOSITE ABSORBENT AND USE THEREOF | Mar 22, 2020 | Pending |
Array
(
[id] => 17837639
[patent_doc_number] => 20220274944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITE ABSORBENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/637241
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637241 | COMPOSITE ABSORBENT AND USE THEREOF | Mar 22, 2020 | Pending |
Array
(
[id] => 17393353
[patent_doc_number] => 11242354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/825251
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9049
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825251 | 4-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereof | Mar 19, 2020 | Issued |
Array
(
[id] => 16625192
[patent_doc_number] => 20210043845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/823210
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823210 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | Mar 17, 2020 | Abandoned |
Array
(
[id] => 16175405
[patent_doc_number] => 20200222373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => RIFABUTIN FOR THE TREATMENT OF ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 16/821861
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821861 | Rifabutin for the treatment of acinetobacter baumannii | Mar 16, 2020 | Issued |
Array
(
[id] => 17563106
[patent_doc_number] => 20220127255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => HERBICIDAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/435253
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 811
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435253 | HERBICIDAL COMPOUNDS | Mar 4, 2020 | Abandoned |